Physician profile
Mathew B Johnson
NPI 1134142334
$14,043.20
in general payments reported to CMS, 2019-2025
14 companies · $55.00 in 2025
The $55.00 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.19 · 2021: $17.89 · 2022: $12K · 2023: $842 · 2024: $1,370 · 2025: $55.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,391 · Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,390.61 |
| Food and Beverage | $875.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,526.77 | 2022-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $153.64 | 2024 | Ovitex 2s |
| Smith+Nephew, INC. | $103.57 | 2022-2025 | Stravix, Stravix Pl, Renasys Go V2 Home |
| Medtronic, INC. | $36.41 | 2021-2022 | |
| Allergan, INC. | $33.40 | 2019 | |
| Stryker Corporation | $28.83 | 2024 | N/A |
| Patterson Companies, INC. | $27.43 | 2022 | |
| Boston Scientific Corporation | $24.89 | 2022-2023 | Spyglass |
| Kerecis Limited | $21.89 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Lemaitre Vascular, INC. | $21.51 | 2024 | Artegraft Vascular Graft |
| Hologic Sales and Service, LLC | $20.23 | 2022 | |
| Davol INC. | $17.01 | 2024 | Arista Ah Flexitip |
| Z-Medica, LLC | $14.79 | 2019 | |
| Abbott Laboratories | $12.83 | 2023 | Agilis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.